{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:07:58Z","timestamp":1779073678896,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,17]]},"DOI":"10.7759\/cureus.109052","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:48:31Z","timestamp":1779072511000},"source":"Crossref","is-referenced-by-count":0,"title":["Behavioral Effects of Renin-Angiotensin System Modulators in a Rotenone-Induced Model of Parkinson\u2019s Disease in Wistar Albino Rats"],"prefix":"10.7759","author":[{"given":"Prakash","family":"KG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saniya","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishwarya","family":"Mantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavrao","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mythili Bai","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Jaju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza C","year":"2019","unstructured":"Raza C, Anjum R, Shakeel NU. Parkinson's disease: mechanisms, translational models and management strategies. Life Sci. 2019, 226:77-90. 10.1016\/j.lfs.2019.03.057","journal-title":"Life Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00170","article-title":"Non-motor symptoms of Parkinson's disease and their impact on quality of life in a cohort of Moroccan patients","volume":"9","author":"Tibar H","year":"2018","unstructured":"Tibar H, El Bayad K, Bouhouche A, et al.. Non-motor symptoms of Parkinson's disease and their impact on quality of life in a cohort of Moroccan patients. Front Neurol. 2018, 9:170. 10.3389\/fneur.2018.00170","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications","volume":"15","author":"Dash UC","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, et al.. Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. Acta Pharm Sin B. 2025, 15:15-34. 10.1016\/j.apsb.2024.10.004","journal-title":"Acta Pharm Sin B"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1788-5","article-title":"Parkinson's disease: experimental models and reality","volume":"135","author":"Jiang P","year":"2018","unstructured":"Jiang P, Dickson DW. Parkinson's disease: experimental models and reality. Acta Neuropathol. 2018, 135:13-32. 10.1007\/s00401-017-1788-5","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03193-8","article-title":"Rotenone-induced model of Parkinson's disease: beyond mitochondrial complex I inhibition","volume":"60","author":"Ibarra-Guti\u00e9rrez MT","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M. Rotenone-induced model of Parkinson's disease: beyond mitochondrial complex I inhibition. Mol Neurobiol. 2023, 60:1929-48. 10.1007\/s12035-022-03193-8","journal-title":"Mol Neurobiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures","volume":"134","author":"Testa CM","year":"2005","unstructured":"Testa CM, Sherer TB, Greenamyre JT. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res Mol Brain Res. 2005, 134:109-18. 10.1016\/j.molbrainres.2004.11.007","journal-title":"Brain Res Mol Brain Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-019-1011-2","article-title":"The renin-angiotensin system in the central nervous system and its role in blood pressure regulation","volume":"22","author":"Nakagawa P","year":"2020","unstructured":"Nakagawa P, Gomez J, Grobe JL, Sigmund CD. The renin-angiotensin system in the central nervous system and its role in blood pressure regulation. Curr Hypertens Rep. 2020, 22:7. 10.1007\/s11906-019-1011-2","journal-title":"Curr Hypertens Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara B","year":"2009","unstructured":"Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009, 7:65-74. 10.2174\/157015909787602823","journal-title":"Curr Neuropharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1137197","article-title":"Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: A nationwide population-based cohort study","volume":"15","author":"Lee HW","year":"2023","unstructured":"Lee HW, Kim S, Jo Y, Kim Y, Ye BS, Yu YM. Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: A nationwide population-based cohort study. Front Aging Neurosci. 2023, 15:1137197. 10.3389\/fnagi.2023.1137197","journal-title":"Front Aging Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18495","article-title":"The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?","volume":"28","author":"Al-Qahtani Z","year":"2024","unstructured":"Al-Qahtani Z, Al-Kuraishy HM, Al-Gareeb AI, et al.. The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?. J Cell Mol Med. 2024, 28:e18495. 10.1111\/jcmm.18495","journal-title":"J Cell Mol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing MF","year":"2002","unstructured":"Festing MF, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002, 43:244-58. 10.1093\/ilar.43.4.244","journal-title":"ILAR J"},{"key":"ref12","article-title":"CPCSEA guidelines for laboratory animal facility","volume":"35","author":"Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA)","year":"2003","unstructured":"Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA). CPCSEA guidelines for laboratory animal facility. Indian J Pharmacol. 2003, 35:257-74.","journal-title":"Indian J Pharmacol"},{"key":"ref13","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta P","year":"2013","unstructured":"Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med. 2013, 4:624-30.","journal-title":"Int J Prev Med"},{"key":"ref14","article-title":"Handbook of experimental pharmacology","author":"Kulkarni SK","year":"2012","unstructured":"Kulkarni SK. Handbook of experimental pharmacology. Vallabh Prakashan, New Delhi; 2012."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"DU NW","year":"1957","unstructured":"DU NW, MI TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc. 1957, 46:208-9. 10.1002\/jps.3030460322","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"key":"ref16","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer OA","year":"1979","unstructured":"Meyer OA, Tilson HA, Byrd WC, Riley MT. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1979, 1:233-6.","journal-title":"Neurobehav Toxicol"},{"key":"ref17","article-title":"Use of a particular mouse reaction (hole board method) for the study of psychotropic drugs (Article in French)","volume":"19","author":"Boissier JR","year":"1964","unstructured":"Boissier JR, Simon P, Lwoff JM. Use of a particular mouse reaction (hole board method) for the study of psychotropic drugs (Article in French). Therapie. 1964, 19:571-83.","journal-title":"Therapie"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru L","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985, 85:367-70. 10.1007\/BF00428203","journal-title":"Psychopharmacology (Berl)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt RD","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977, 266:730-2. 10.1038\/266730a0","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow S","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985, 14:149-67. 10.1016\/0165-0270(85)90031-7","journal-title":"J Neurosci Methods"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer TB","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, et al.. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci. 2003, 23:10756-64. 10.1523\/JNEUROSCI.23-34-10756.2003","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet R","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000, 3:1301-6. 10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson's disease","volume":"211","author":"Bov\u00e9 J","year":"2012","unstructured":"Bov\u00e9 J, Perier C. Neurotoxin-based models of Parkinson's disease. Neuroscience. 2012, 211:51-76. 10.1016\/j.neuroscience.2011.10.057","journal-title":"Neuroscience"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases","volume":"465","author":"Wright JW","year":"2013","unstructured":"Wright JW, Harding JW. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch. 2013, 465:133-51. 10.1007\/s00424-012-1102-2","journal-title":"Pflugers Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496604-behavioral-effects-of-renin-angiotensin-system-modulators-in-a-rotenone-induced-model-of-parkinsons-disease-in-wistar-albino-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:48:33Z","timestamp":1779072513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496604-behavioral-effects-of-renin-angiotensin-system-modulators-in-a-rotenone-induced-model-of-parkinsons-disease-in-wistar-albino-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.109052","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,17]]}}}